Matthew C. Biery

Center for Cancer and Blood Disorders — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index2.2kcitations64works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(18), Glioma Diagnosis and Treatment(18), RNA modifications and cancer(14), RNA Research and Splicing(9), Protein Degradation and Inhibitors(8)

Publications64 total

Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma
Neuro-Oncology·2026· 1 cited
Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy
Neuro-Oncology Advances·2025Open Access
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma
2025Open Access
Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain Tumors
2025Open Access
DIPG-11. PRECLINICAL EFFICACY OF B7-H3 CAR T CELLS IN COMBINATION WITH ONC206
Neuro-Oncology·2024Open Access
Abstract 525: A comprehensive approach: Copper chelation therapy modulates epigenetic, kinase signaling and metabolic pathways in diffuse midline gliomas (DMG)
Cancer Research·2024· 1 cited
DIPG-29. A CONNECT CONSORTIUM PRECLINICAL STUDY IDENTIFIES MEK INHIBITION AND RADIATION AS POTENTIAL COMBINATION PARTNERS FOR THE ALK2 INHIBITOR TP-0184 IN ACVR1-MUTANT DMG
Neuro-Oncology·2023Open Access
IMMU-13. PRECLINICAL EFFICACY OF MULTI-ANTIGEN (HER2/EGFR806/B7-H3/IL13RA2) TARGETING QUAD-CAR T CELLS AGAINST DIFFUSE MIDLINE GLIOMA
Neuro-Oncology·2023Open Access
DIPG-47. DISCOVERING A MOLECULAR BASIS FOR VULNERABILITY OF H3K27M-DMG TO HISTONE DEACETYLASE INHIBITORS
Neuro-Oncology·2023Open Access
Abstract 4740: Molecular effects of histone deacetylase inhibitor Quisinostat on diffuse midline glioma of the pons
Cancer Research·2023
Supplementary Table B from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table E from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table A from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table E from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Figure and Table Legends from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table B from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table D from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Table C from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Data from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
Supplementary Figure A from Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Peter S. Linsley(17), Nicholas A. Vitanza(16), Michael Carleton(14), Aimee L. Jackson(12), Janell M. Schelter(11), Michele A. Cleary(11), Sara A. Georges(10), Soo‐Yeon Kim(10), Jane Guo(10), Aaron N. Chang(10), Carrie Myers(9), James M. Olson(9), B. Nelson Chau(9), Mao Mao(6), Javad Nazarian(6), Sumire Kobayashi(5), John C. Castle(5), Justyna M. Przystal(5), Sridevi Yadavilli(5), Carl Koschmann(5)